Skip to main content
SHIELD THERAPEUTICS PLC logo

SHIELD THERAPEUTICS PLC — Investor Relations & Filings

Ticker · STX ISIN · GB00BYV81293 LEI · 213800G74QWY15FC3W71 IL Manufacturing
Open in API
Filings indexed 408 across all filing types
Latest filing 2022-07-08 AGM Information
Country GB United Kingdom
Listing IL STX

About SHIELD THERAPEUTICS PLC

https://www.shieldtherapeutics.com/

Shield Therapeutics is a commercial-stage specialty pharmaceutical company focused on addressing iron deficiency. The company's mission is to improve the lives of patients suffering from this condition, with or without anemia. Its lead product is Accrufer® (ferric maltol), also marketed as Feraccru®, a novel, stable, non-salt-based oral therapy. This innovative pharmaceutical is broadly indicated for use in adults across multiple therapeutic categories, aiming to provide an effective and well-tolerated treatment for a significant unmet medical need.

Recent filings

Filing Released Lang Actions
Notice of General Meeting
AGM Information Classification · 98% confidence The document is a formal announcement from Shield Therapeutics plc, identified by the RNS Number and the London Stock Exchange context. The core content is a 'Notice of General Meeting' scheduled for July 27, 2022, which is being held to consider resolutions related to a shareholder loan conversion right. This notice informs shareholders about the meeting logistics and the documents sent to them. Since it is a notice regarding a shareholder meeting and the associated voting/procedural matters, it strongly relates to the governance and shareholder interaction surrounding a meeting. While it mentions the AGM is due to be held earlier, the primary purpose of this specific filing is the 'Notice of General Meeting'. This type of announcement, which informs shareholders about a meeting and its purpose, is closely related to the materials used to solicit votes or provide information for such meetings. However, the document explicitly announces the sending of the 'Notice of General Meeting' and provides details for attendance, which is a key component of shareholder communication leading up to a vote. Given the options, 'AGM-R' (AGM Information) is plausible if the General Meeting is the AGM, but the text separates the General Meeting from the AGM which is 'due to be held at 2pm'. The document is essentially a formal notice about an upcoming shareholder meeting and the associated procedural steps. This fits best under the umbrella of shareholder communication regarding meetings, which is covered by AGM-R (if it's the AGM) or potentially RNS as a general regulatory filing. Since it specifically concerns a 'General Meeting' and the resolutions to be passed there, and it is not the proxy statement itself (PSI), the most fitting category related to meeting materials/announcements is AGM-R, as General Meetings often encompass the AGM or are closely related in context. Given the document's nature as a formal notice about a meeting where resolutions will be passed, AGM-R is the most specific fit among the choices related to meetings.
2022-07-08 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1935 characters) and announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange, identified by the 'RNS Number : 8995Q'. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, and is approved by the Financial Conduct Authority (FCA). This type of brief, time-sensitive market operational announcement that does not fit into specific financial reporting categories (like 10-K, ER, or IR) is best classified as a general Regulatory Filing or announcement. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for miscellaneous regulatory announcements that are not covered by other specific codes.
2022-06-30 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1918 characters) and its primary content is an announcement regarding a 'Price Monitoring Extension' for a security, referencing the 'National Storage Mechanism' and 'RNS Number : 8982Q'. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, and mentions compliance with FCA regulations for Primary Information Providers. This is a brief, specific regulatory update that does not fit the definitions for formal reports (10-K, IR, ER, AR) or specific corporate actions (DIV, DIRS, MANG). Since it is a general regulatory announcement disseminated via the RNS system and doesn't fit a more specific category, the most appropriate classification is the general regulatory fallback.
2022-06-30 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1935 characters) and contains the header 'RNS Number : 8719Q'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. This is a specific, non-standard regulatory announcement concerning trading halts or extensions, which does not fit into the defined categories like ER, 10-K, or DIV. Since it is a direct, immediate regulatory notification provided via the RNS service, and it doesn't announce the publication of a larger report (ruling #2), the most appropriate classification is the general Regulatory Filings category (RNS), which serves as the fallback for miscellaneous regulatory announcements.
2022-06-30 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1918 characters) and contains the header 'RNS Number : 8708Q'. It announces a 'Price Monitoring Extension' related to trading procedures on the London Stock Exchange and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure—a brief announcement about a market event or administrative update provided directly by the RNS service—fits the definition of a general regulatory announcement that doesn't fit a specific financial report category. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-06-30 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1935 characters) and contains an 'RNS Number' header, indicating it is a regulatory announcement disseminated via the London Stock Exchange's news service (RNS). The content describes a 'Second Price Monitoring Extension' for a security, which is a specific operational notice related to trading halts or volatility controls, not a comprehensive financial report (like 10-K or IR) or a standard corporate action announcement (like DIV or ER). Since it is a general regulatory announcement that doesn't fit the highly specific categories like DIRS, DIV, or ER, and it is clearly an RNS dissemination, the most appropriate classification is the general regulatory filing fallback category, RNS.
2022-06-30 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.